HPV jab which uses same technology as AstraZeneca Covid vaccine could combat cervical cancer in adults
Trial is under way at several NHS hospitals giving more than 50 women who test positive for pre-cancerous tissue on their cervix a specially designed HPV jab Researchers will examine whether pre-cancerous tissue is still on the cervix, along with any traces of HPV (human papillomavirus), an infection almost always present when women develop this cancer The trial, called Apollo, involves a vaccine called VTP-200, which targets HPV It is different from HPV jab given to teenagers as it uses an inactivated chimpanzee adenovirus – same technology as in AstraZeneca Covid jab By Ethan Ennals For The Mail On Sunday
Published: 23:55 BST, 30 April 2022 | Updated: 23:59 BST, 30 April 2022
The ground-breaking technology behind the Oxford-AstraZeneca Covid vaccine could be used to combat cervical cancer, potentially wiping out early signs of the disease before it has time to progress.
A trial is under way at several NHS hospitals giving more than 50 women who test positive for pre-cancerous tissue on their cervix a specially designed HPV jab.
After a year, researchers will examine whether the pre-cancerous tissue is still on the cervix, along with any traces of HPV (human papillomavirus), an infection which is almost always present when women develop this cancer.
The trial, called Apollo, involves a vaccine called VTP-200, which targets HPV but is different from the HPV jab given to teenagers as it uses an inactivated chimpanzee adenovirus – the same
read more from dailymail.....
Tags
fashion
wedding
dress
style
tv mount
Amazon
news
lifestyle
Celebrity News
Kim Kardashian
vichy
neal's yard
aubrey organics
neal's yard remedies
babo botanicals
kiehls store
the body
american auto insurance
auto policy quote
auto quotes online
instant car insurance quote
buy car insurance online